Leaderboards/Cerebrovascular and genetic disorders

Cerebrovascular and genetic disorders

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Xiaoxiao Zheng
Jilin University
2
Jessica Walsh
University of Washington
3
Bernard P. H. Cho
University of Cambridge
4
Liu‐Yun Wu
National University of Singapore
5
Remco J. Hack
Leiden University Medical Center
6
Gido Gravesteijn
Leiden University Medical Center
7
Milagros C. Romay
University of California, Los Angeles
8
Sabrina Ng
Icahn School of Medicine at Mount Sinai
9
Michael Tran Duong
University of Pennsylvania
10
Amy A. Jolly
University of Cambridge

Papers

1
Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP)
European journal of medical research|2024
73 cit.
2
Blood-based biomarkers of cerebral small vessel disease
Ageing Research Reviews|2024
48 cit.
3
Disease Severity Staging System for <i>NOTCH3</i>-Associated Small Vessel Disease, Including CADASIL
JAMA Neurology|2024
17 cit.
4
Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer’s Disease
Journal of Alzheimer s Disease|2024
15 cit.
5
Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer’s and Lewy body disease
Brain|2024
15 cit.
6
Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients
Open Forum Infectious Diseases|2024
10 cit.
7
Region-specific gene expression and sex inform about disease susceptibility in the aorta
Nature Cardiovascular Research|2025
5 cit.
8
Rare Sequence Variation Underlying Suspected Familial Cerebral Small‐Vessel Disease
Journal of the American Heart Association|2024
3 cit.
9
Publication in Movement Disorders (2026) [2 citations, W7125970414]
Movement Disorders|2026
2 cit.
10
Publication in BJR|case reports (2025) [1 citation, W4408741575]
BJR|case reports|2025
1 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Frank M. J. Jacobs
Netherlands Institute for Neuroscience
2
Susanne J. van Veluw
Massachusetts General Hospital
3
Alain Martelli
Pfizer (United States)
4
Saisudha Koka
University of Tübingen
5
Chaodong Wang
University of Electronic Science and Technology of China
6
Julie W. Rutten
Leiden University Medical Center
7
Zhengshan Zhang
Chinese PLA General Hospital
8
Ling Wei
Shandong Tumor Hospital
9
Tao Wang
University of Manchester
10
Xia Meng
Capital Medical University

Papers

1
Blood–brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy
Brain Communications|2022
90 cit.
2
In vivo overexpression of frataxin causes toxicity mediated by iron-sulfur cluster deficiency
Molecular Therapy — Methods & Clinical Development|2022
56 cit.
3
ACO2 deficiency increases vulnerability to Parkinson’s disease via dysregulating mitochondrial function and histone acetylation-mediated transcription of autophagy genes
Communications Biology|2023
32 cit.
4
A hidden layer of structural variation in transposable elements reveals potential genetic modifiers in human disease-risk loci
Genome Research|2022
29 cit.
5
Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample
Neurology|2023
25 cit.
6
Automatic Epileptic Seizure Detection Using PSO-Based Feature Selection and Multilevel Spectral Analysis for EEG Signals
Journal of Sensors|2022
24 cit.
7
Spontaneous vasomotion propagates along pial arterioles in the awake mouse brain like stimulus-evoked vascular reactivity
Journal of Cerebral Blood Flow & Metabolism|2023
24 cit.
8
Cerebral Amyloid Angiopathy
Stroke|2024
24 cit.
9
Corpus callosum lesions are associated with worse cognitive performance in cerebral amyloid angiopathy
Brain Communications|2022
19 cit.
10
Histopathological correlates of haemorrhagic lesions on <i>ex vivo</i> magnetic resonance imaging in immunized Alzheimer’s disease cases
Brain Communications|2022
17 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Martin Dichgans
Munich Cluster for Systems Neurology
2
Elisabeth Tournier‐Lasserve
Inserm
3
Hugues Chabriat
Université Paris Cité
4
Hugh S. Markus
University of Cambridge
5
Anne Joutel
Institut de Psychiatrie et Neurosciences de Paris
6
Julie A. Schneider
University of California San Diego
7
John Q. Trojanowski
University of Pennsylvania
8
Raphael Kopan
University of Cincinnati Medical Center
9
Raj N. Kalaria
Newcastle Hospitals - Campus for Ageing and Vitality
10
Steven M. Greenberg
Harvard University

Papers

1
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
The Lancet Neurology|2013
5.4k cit.
2
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
The Lancet Neurology|2009
4.8k cit.
3
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
The Lancet Neurology|2013
4.4k cit.
4
Neurodegenerative Tauopathies
Annual Review of Neuroscience|2001
2.4k cit.
5
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
Nature|1999
2.1k cit.
6
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Nature|1996
2.1k cit.
7
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Neurology|2007
2k cit.
8
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
Nature|1998
1.6k cit.
9
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Brain|2019
1.5k cit.
10
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Science|1991
1.4k cit.

Reagents for Cerebrovascular and genetic disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Integrin beta1 (D6S1W) Rabbit Monoclonal Antibody

#34971$152,351
View Evidence →
Cell Signaling Technology

Phospho-AMPK beta1 (Ser182) Antibody

#4186$362
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-Chk2 (Thr68) (C13C1) Rabbit Monoclonal Antibody

#2197$169,411
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

HSP90 (C45G5) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Red 780 Conjugate)

Cited in 6 papers
#34412$458
View Evidence →
Cell Signaling Technology

Total AMPK alpha Matched Antibody Pair

#74094$1,726
View Evidence →
Agilent/Dako

Neurofilament Protein

#M0762
View Evidence →